Cargando…

ESSKA consensus initiative: why, when and how?

The goal of a Consensus in clinical practice is to provide daily practitioners with evidence- based recommendations on data from the literature, clinical expertise and expectations of professionals and patients. In this context, a consensus aligns with the principles of evidence-based medicine in cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beaufils, Philippe, Dejour, David, Filardo, Giuseppe, Monllau, Joan Carles, Menetrey, Jacques, Seil, Romain, Becker, Roland
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558408/ https://www.ncbi.nlm.nih.gov/pubmed/37801160 http://dx.doi.org/10.1186/s40634-023-00664-2

Ejemplares similares

Management of traumatic meniscus tears: the 2019 ESSKA meniscus consensus
por: Kopf, Sebastian, et al.
Publicado: (2020)

Management of anterior cruciate ligament revision in adults: the 2022 ESSKA consensus: part II—surgical strategy
por: Condello, Vincenzo, et al.
Publicado: (2023)

Surgical Management of Degenerative Meniscus Lesions: The 2016 ESSKA Meniscus Consensus
por: Beaufils, P., et al.
Publicado: (2017)

Surgical management of degenerative meniscus lesions: the 2016 ESSKA meniscus consensus
por: Beaufils, Ph, et al.
Publicado: (2017)

COVID-19 - ESSKA guidelines and recommendations for resuming elective surgery
por: Mouton, Caroline, et al.
Publicado: (2020)

Preliminary experience of an international orthopaedic registry: the ESSKA Paediatric Anterior Cruciate Ligament Initiative (PAMI) registry
por: Mouton, Caroline, et al.
Publicado: (2021)

Management of anterior cruciate ligament revision in adults: the 2022 ESSKA consensus part III—indications for different clinical scenarios using the RAND/UCLA appropriateness method
por: Tischer, Thomas, et al.
Publicado: (2023)

The ESSKA-AFAS international consensus statement on peroneal tendon pathologies
por: van Dijk, Pim A., et al.
Publicado: (2018)

ESSKA and EBJIS recommendations for the management of infections after anterior cruciate ligament reconstruction (ACL-R): prevention, surgical treatment and rehabilitation
por: Pérez-Prieto, Daniel, et al.
Publicado: (2023)

Editorial (ESSKA-SHPS supplement)
por: Randelli, Filippo, et al.
Publicado: (2021)

Current trends in tendinopathy: consensus of the ESSKA basic science committee. Part II: treatment options
por: Abat, F., et al.
Publicado: (2018)

Platelet Rich Plasma and Orthopedics: Why, When, and How
por: Sánchez, Mikel, et al.
Publicado: (2015)

The Top 100 Most Cited Articles on Platelet-Rich Plasma Use in Regenerative Medicine—A Bibliometric Analysis—From the ESSKA Orthobiologic Initiative
por: Coulange Zavarro, Anouck, et al.
Publicado: (2022)

The future of meniscus science: international expert consensus
por: DePhillipo, Nicholas N., et al.
Publicado: (2021)

A new basic science journal for ESSKA
por: Karlsson, Jon, et al.
Publicado: (2014)

From meniscal resection to meniscal repair: a journey of the last decade
por: Becker, Roland, et al.
Publicado: (2020)

High degree of consensus achieved regarding diagnosis and treatment of acromioclavicular joint instability among ESA-ESSKA members
por: Rosso, Claudio, et al.
Publicado: (2020)

Current trends in tendinopathy: consensus of the ESSKA basic science committee. Part I: biology, biomechanics, anatomy and an exercise-based approach
por: Abat, F., et al.
Publicado: (2017)

Does practice of meniscus surgery change over time? A report of the 2021 ‘THE MENISCUS’ Webinar
por: Jacquet, Christophe, et al.
Publicado: (2021)

Cell-based therapies have disease-modifying effects on osteoarthritis in animal models. A systematic review by the ESSKA Orthobiologic Initiative. Part 1: adipose tissue-derived cell-based injectable therapies
por: Perucca Orfei, Carlotta, et al.
Publicado: (2022)

Cell-based therapies have disease-modifying effects on osteoarthritis in animal models. A systematic review by the ESSKA Orthobiologic Initiative. Part 2: bone marrow-derived cell-based injectable therapies
por: Boffa, Angelo, et al.
Publicado: (2023)

Not if but when; no longer why but how
por: Piper, Ian
Publicado: (2007)

When Apnea Turns Terminal: When, How, Why?
por: Goldman, Alica M.
Publicado: (2021)

Birth Control: Why, When and How?
Publicado: (1940)

Loss of Migraine: When, Why and How
por: Blau, J. N.
Publicado: (1987)

Surgical Stillness—When, Why, and How?
por: Rosenberg, Jacob, et al.
Publicado: (2019)

Research Funding—Why, When, and How?
por: Neema, Shekhar, et al.
Publicado: (2021)

Immunotherapy in myeloma: Why, when and how?
por: van de Donk, Niels W.C.J.
Publicado: (2018)

Sarcopenia: how to measure, when and why
por: Tagliafico, Alberto Stefano, et al.
Publicado: (2022)

Calcifediol: Why, When, How Much?
por: Donati, Simone, et al.
Publicado: (2023)

The aspiration test reveals an instability of the posterior horn of the lateral meniscus in almost one-third of ACL-injured patients
por: Jacquet, Christophe, et al.
Publicado: (2021)

Mitotic Recombination: Why? When? How? Where?
por: LaFave, Matthew C., et al.
Publicado: (2009)

N-acetylcysteine in COPD: why, how, and when?
por: Sanguinetti, Claudio M.
Publicado: (2016)

Cardiac papillary fibroelastoma; when, how, why?
por: Baikoussis, Nikolaos G., et al.
Publicado: (2016)

Adapting improvements to context: when, why and how?
por: Ovretveit, John, et al.
Publicado: (2018)

Pediatric eye screening – Why, when, and how
por: Honavar, Santosh G
Publicado: (2018)

The why, when, and how of computing in biology classrooms
por: Wright, April M., et al.
Publicado: (2020)

Adapting improvements to context: when, why and how?
por: Ovretveit, John, et al.
Publicado: (2018)

Ceftolozane-tazobactam: When, how and why using it?
por: López, Inmaculada, et al.
Publicado: (2021)

Cancer-associated thrombosis: the when, how and why
por: Fernandes, Caio J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hhqd4s8amabe6og4enclhqvc4g